ID

23501

Descripción

A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00559754

Link

https://clinicaltrials.gov/show/NCT00559754

Palabras clave

  1. 8/7/17 8/7/17 -
Subido en

8 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00559754

Eligibility Breast Cancer NCT00559754

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients, >=18 years of age;
Descripción

Gender | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
primary her2-negative operable breast cancer;
Descripción

Breast Carcinoma Primary HER2 negative Operable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0205225
UMLS CUI [1,3]
C4087376
UMLS CUI [1,4]
C0205188
tumor >2cm in size;
Descripción

Tumor size

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0475440
ecog performance status 0-1.
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment for breast cancer;
Descripción

Prior Therapy Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0678222
metastatic disease;
Descripción

Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027627
current or recent (within 10 days of first dose of avastin) use of aspirin (>325mg/day) or full-dose anticoagulants for therapeutic purposes;
Descripción

Aspirin U/day | Avastin | Anticoagulants Dose Full

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
UMLS CUI [2]
C1135130
UMLS CUI [3,1]
C0003280
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0443225
clinically significant cardiovascular disease.
Descripción

Cardiovascular Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222

Similar models

Eligibility Breast Cancer NCT00559754

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
female patients, >=18 years of age;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Breast Carcinoma Primary HER2 negative Operable
Item
primary her2-negative operable breast cancer;
boolean
C0678222 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C4087376 (UMLS CUI [1,3])
C0205188 (UMLS CUI [1,4])
Tumor size
Item
tumor >2cm in size;
boolean
C0475440 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Therapy Breast Carcinoma
Item
previous treatment for breast cancer;
boolean
C1514463 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
Neoplasm Metastasis
Item
metastatic disease;
boolean
C0027627 (UMLS CUI [1])
Aspirin U/day | Avastin | Anticoagulants Dose Full
Item
current or recent (within 10 days of first dose of avastin) use of aspirin (>325mg/day) or full-dose anticoagulants for therapeutic purposes;
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C1135130 (UMLS CUI [2])
C0003280 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0443225 (UMLS CUI [3,3])
Cardiovascular Diseases
Item
clinically significant cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial